Cargando…
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
Current therapeutic options for cryptococcal meningitis are limited by toxicity, global supply, and emergence of resistance. There is an urgent need to develop additional antifungal agents that are fungicidal within the central nervous system and preferably orally bioavailable. The benzimidazoles ha...
Autores principales: | Nixon, Gemma L., McEntee, Laura, Johnson, Adam, Farrington, Nicola, Whalley, Sarah, Livermore, Joanne, Natal, Cristien, Washbourn, Gina, Bibby, Jaclyn, Berry, Neil, Lestner, Jodi, Truong, Megan, Owen, Andrew, Lalloo, David, Charles, Ian, Hope, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913986/ https://www.ncbi.nlm.nih.gov/pubmed/29311092 http://dx.doi.org/10.1128/AAC.01909-17 |
Ejemplares similares
-
Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
por: Lestner, Jodi, et al.
Publicado: (2017) -
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
por: Kovanda, Laura L., et al.
Publicado: (2019) -
Gelatinous pseudocysts in cryptococcal meningoencephalitis
por: Ribeiro, Bruno Niemeyer de Freitas, et al.
Publicado: (2020) -
An Uncommon Presentation of Cryptococcal Meningoencephalitis
por: Freitas, Isabel, et al.
Publicado: (2022) -
Cryptococcal Meningoencephalitis in Phenotypically Normal Patients
por: Cumagun, Pia M., et al.
Publicado: (2023)